AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
Nov 2, 2011
30583_dirs_2011-11-02_5c253722-22ac-4aec-acea-eea452a246b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-11-01
Reporting Person: Davis George Eric (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-31 | Common Stock | A | 260 | $13.226 | Acquired | 39911 | Direct |
| 2011-11-01 | Common Stock | S | 260 | $33.234 | Disposed | 39651 | Direct |
Footnotes
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 29, 2011 to October 31, 2011.
F2: Transaction made pursuant to a Rule 10b5-1 Trading Plan, executed March 14, 2011.
F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $32.94 to $33.725. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.